Marino Garcia
CEO and President at Dianthus Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 2 boards, counting each seat separately. Longest: Dianthus Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Dianthus Therapeutics Inc. May 22, 202591.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 7, 2026 | Dianthus Therapeutics Inc. | Option exercise | +40,000 | $8.44 | $337,600 |
| Aug 7, 2026 | Dianthus Therapeutics Inc. | Option exercise | +126,000 | $8.44 | $1,063,440 |
| Aug 7, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −10,384 | $107.49 | $1,116,176 |
| Aug 7, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −23,907 | $108.05 | $2,583,151 |
| Aug 7, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −2,373 | $109.10 | $258,894 |
| Aug 7, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −2,536 | $110.02 | $279,011 |
| Aug 7, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −800 | $110.76 | $88,608 |
| Aug 7, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −104,091 | $107.96 | $11,237,664 |
| Aug 7, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −21,909 | $108.72 | $2,381,946 |
| Mar 16, 2026 | Dianthus Therapeutics Inc. | Option exercise | +59,700 | $6.70 | $399,990 |
| Mar 16, 2026 | Dianthus Therapeutics Inc. | Option exercise | +5,592 | $17.88 | $99,985 |
| Mar 12, 2026 | Dianthus Therapeutics Inc. | Option exercise | +122,918 | $6.70 | $823,551 |
| Mar 12, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −43,505 | $80.69 | $3,510,418 |
| Mar 12, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −65,517 | $81.74 | $5,355,360 |
| Mar 12, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −12,796 | $82.60 | $1,056,950 |
Questions about Marino Garcia
What boards is Marino Garcia on?
Marino Garcia sits on the boards of AgomAb Therapeutics NV and Dianthus Therapeutics Inc.
What company is Marino Garcia the CEO of?
Marino Garcia has been CEO and President of Dianthus Therapeutics Inc. since September 2023.
How long has Marino Garcia served on boards?
Our records show at least 3 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.